These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39277020)

  • 21. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
    Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
    J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance Evaluation of the Luminex Aries C. difficile Assay in Comparison to Two Other Molecular Assays within a Multihospital Health Care Center.
    Juretschko S; Manji R; Khare R; Das S; Dunbar S
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31413082
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.
    Hara T; Suzuki H; Oyanagi T; Koyanagi N; Ushiki A; Kawabata N; Goto M; Hida Y; Yaguchi Y; Tamai K; Notake S; Kawashima Y; Sugiyama A; Uemura K; Kashiyama S; Nanmoku T; Suzuki S; Yamazaki H; Kimura H; Kunishima H; Ohge H
    PLoS One; 2020; 15(6):e0234119. PubMed ID: 32492051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of five assays for detection of Clostridium difficile toxin.
    Chapin KC; Dickenson RA; Wu F; Andrea SB
    J Mol Diagn; 2011 Jul; 13(4):395-400. PubMed ID: 21704273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
    Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
    J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a nucleic acid amplification assay for the diagnosis of Clostridioides difficile infection.
    Koyuncu-Ozyurt O; Ozhak B; Ogunc D; Ongut G; Gunseren F; Donmez L; Colak D
    Anaerobe; 2019 Oct; 59():201-204. PubMed ID: 31255716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
    Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
    Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory.
    Zidarič V; Kotnik Kevorkijan B; Oresic N; Janezic S; Rupnik M
    J Med Microbiol; 2011 Aug; 60(Pt 8):1131-1136. PubMed ID: 21372187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Copan FecalSwab as Specimen Type for Use in Xpert C. difficile Assay.
    Mashock MJ; Faron ML; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2017 Oct; 55(10):3123-3129. PubMed ID: 28794179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.